title: IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).
abstract: Blood concentrations of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) have recently been associated with breast cancer risk, notably in women who developed breast cancer at a young age. Prospective studies published so far, however, were relatively small and odds ratio (OR) estimates imprecise. We present the results of a large prospective case-control study nested within the European Prospective Investigation into Cancer and Nutrition on total IGF-I, IGFBP-3 and breast cancer risk including 1081 incident cases of invasive breast cancer and 2098 matched control subjects. Increasing IGF-I and IGFBP-3 concentrations were associated with a significant increase in breast cancer risk in women who developed breast cancer after 50 years of age (highest vs lowest quintile OR 1.38 (95% confidence interval (CI) 1.02-1.86), P = 0.01, and 1.44 (95% CI 1.04-1.98), P = 0.01, respectively), but no relationship was observed in younger women (OR = 1.03 (95% CI 0.60-1.77), P = 0.81 for IGF-I, and OR = 0.92 (95% CI 0.50-1.70), P = 0.69 for IGFBP-3). There was, however, significant heterogeneity in the relationship of breast cancer with serum IGF-I and IGFBP-3 levels depending on the time interval between blood donation and tumor diagnosis. A reduction in breast cancer risk with increasing IGF-I concentrations was observed in cases with a diagnosis of cancer less than 2 years after blood donation, (OR = 0.76 (95% CI 0.57-1.03)), while an increase in risk was observed for women with a later diagnosis (above or equal to two years after blood collection, OR = 1.51 (95% CI 1.19-1.91)). A similar pattern was observed for IGFBP-3. This study confirms previous findings for an association of serum IGF-I and IGFBP-3 concentrations with breast cancer risk, particularly for women with a later diagnosis of cancer, but it does not support the hypothesis of an involvement of IGF-I in younger women.
authors.affiliation: International Agency for Research on Cancer (IARC-WHO), 150 Cours Albert Thomas, 69372 Lyon, Cédex 08, France.
authors.forename: S
authors.initials: S
authors.lastname: Rinaldi
authors.forename: P H M
authors.initials: PH
authors.lastname: Peeters
authors.forename: F
authors.initials: F
authors.lastname: Berrino
authors.forename: L
authors.initials: L
authors.lastname: Dossus
authors.forename: C
authors.initials: C
authors.lastname: Biessy
authors.forename: A
authors.initials: A
authors.lastname: Olsen
authors.forename: A
authors.initials: A
authors.lastname: Tjonneland
authors.forename: K
authors.initials: K
authors.lastname: Overvad
authors.forename: F
authors.initials: F
authors.lastname: Clavel-Chapelon
authors.forename: M C
authors.initials: MC
authors.lastname: Boutron-Ruault
authors.forename: B
authors.initials: B
authors.lastname: Téhard
authors.forename: G
authors.initials: G
authors.lastname: Nagel
authors.forename: J
authors.initials: J
authors.lastname: Linseisen
authors.forename: H
authors.initials: H
authors.lastname: Boeing
authors.forename: P H
authors.initials: PH
authors.lastname: Lahmann
authors.forename: A
authors.initials: A
authors.lastname: Trichopoulou
authors.forename: D
authors.initials: D
authors.lastname: Trichopoulos
authors.forename: M
authors.initials: M
authors.lastname: Koliva
authors.forename: D
authors.initials: D
authors.lastname: Palli
authors.forename: S
authors.initials: S
authors.lastname: Panico
authors.forename: R
authors.initials: R
authors.lastname: Tumino
authors.forename: C
authors.initials: C
authors.lastname: Sacerdote
authors.forename: C H
authors.initials: CH
authors.lastname: van Gils
authors.forename: P
authors.initials: P
authors.lastname: van Noord
authors.forename: D E
authors.initials: DE
authors.lastname: Grobbee
authors.forename: H B
authors.initials: HB
authors.lastname: Bueno-de-Mesquita
authors.forename: C A
authors.initials: CA
authors.lastname: Gonzalez
authors.forename: A
authors.initials: A
authors.lastname: Agudo
authors.forename: M D
authors.initials: MD
authors.lastname: Chirlaque
authors.forename: A
authors.initials: A
authors.lastname: Barricarte
authors.forename: N
authors.initials: N
authors.lastname: Larrañaga
authors.forename: J R
authors.initials: JR
authors.lastname: Quiros
authors.forename: S
authors.initials: S
authors.lastname: Bingham
authors.forename: K T
authors.initials: KT
authors.lastname: Khaw
authors.forename: T
authors.initials: T
authors.lastname: Key
authors.forename: N E
authors.initials: NE
authors.lastname: Allen
authors.forename: A
authors.initials: A
authors.lastname: Lukanova
authors.forename: N
authors.initials: N
authors.lastname: Slimani
authors.forename: R
authors.initials: R
authors.lastname: Saracci
authors.forename: E
authors.initials: E
authors.lastname: Riboli
authors.forename: R
authors.initials: R
authors.lastname: Kaaks
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000453:epidemiology*; D016022:Case-Control Studies; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008875:Middle Aged; D009747:Nutritional Physiological Phenomena; D012307:Risk Factors
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I